September 5th – 8th
Congratulations for making it through another week! Here are your recent updates in the world of medical research and policy.
In a study, researchers found that routine hormonal treatment for early prostate cancer may be linked to an increased risk of heart disease.
The cause of this is not clear. Researchers suggest closer monitoring for at-risk men who are receiving treatment.
People living with rheumatoid arthritis (RA) are at increased risk of shingles.
For those on biologics, a shingles vaccine followed by a 2-week delay is generally recommended. Less is known about how to give shingles shots if a patient is on tofacitinib (Xeljanz) for RA.
A study found that people over 50 should wait 2-3 weeks after their shingles shot before starting tofacitinib.
Canakinumab (Ilaris) is an anti-inflammatory biologic. Studies published recently showed that canakinumab may offer protection against some heart diseases and was tied to significantly lower risk of lung cancer.
Sounds impressive, but did you know that Aspirin might give the same degree of protection against heart disease and cancer? Albeit colorectal cancer and not lung cancer, but still.
In a large analysis of trials, cognitive behavioral therapy (CBT) and meds (SSRI only) were both effective at reducing anxiety symptoms.
CBT was safer than meds, and outperformed fluoxetine (Prozac) for symptom reduction; and sertraline (Zoloft) for improved remission.
Like what you see? Subscribe to the newsletter below, and drop by Twitter to say ‘hi’ 🤓.